Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Center for Biologics Evaluation and Research (CBER)

Center for Biologics Evaluation and Research (CBER)

                        CBER Offices & Divisions
          CBER Vision & Mission
          CBER Reports
          CBER Ombudsman
          CBER Product Jurisdiction
          Jobs at the Center for Biologics Evaluation and Research (CBER) Home
          About FDA
          FDA Organization
          Center for Biologics Evaluation and Research (CBER)
          Staff Fellow/Visiting Associate – Pharmacology/Toxicology ReviewerCenter for Biologics Evaluation and Research (CBER) Staff Fellow/Visiting Associate – Pharmacology/Toxicology Reviewer
  
  	
    Share
    Post
    Linkedin

    Email
    Print**Cell Therapies, Gene Therapies, and Plasma Therapeutic Products**
OFFICE OF THERAPEUTIC PRODUCTS (OTP)
CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)
FOOD AND DRUG ADMINISTRATION (FDA)
DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)

The FDA’s Center for Biologics Evaluation and Research (CBER), Office of Therapeutic Products (OTP), Office of Pharmacology/Toxicology (OPT) is recruiting to fill multiple Staff Fellow/Visiting Associate positions to serve as **Pharmacology/Toxicology Reviewers**.

We encourage outstanding scientists and biomedical engineers with training and/or experience in **Immunology/Immunotherapy, Molecular Biology, Cell Biology, Virology, Infectious Disease, Gene Therapy, Genetic Engineering, Regenerative Medicine/Tissue Engineering, Pharmacology/Toxicology,** and/or **Veterinary Sciences** to apply!

The Office of Pharmacology/Toxicology is strongly committed to bringing scientists, patient advocates, and the public together in partnership to develop novel advanced therapies, while protecting human subjects and ensuring product safety and quality.

The selected candidate will join a top group of scientists and engineers in a fast-paced scientific and regulatory environment. The candidate will work within a multidisciplinary team of scientists, clinicians, and biostatisticians to perform assessments of cutting-edge scientific and regulatory information for novel cell and gene therapy products submitted by top academics, small and large biotech companies, as well as large pharmaceutical companies. The candidate may also have opportunities to contribute to FDA policy and guidance development activities in a wide range of areas relevant to the regulation of innovative cell and gene therapy products.

**RESPONSIBILITIES:** As a Pharmacology/Toxicology Reviewer, the candidate will perform the following major duties:

Serves as the primary preclinical reviewer for regulatory submissions on a multidisciplinary team.
	Evaluates preclinical data during premarket review of investigational products. Product types include genetically modified cells, viral and non-viral vectors for gene therapy, genome editing products, stem cell-derived products, immunotherapies, therapeutic vaccines, products for xenotransplantation, etc.
	Provides science-based written and verbal feedback to sponsors regarding the design of their preclinical development program prior to investigational new drug (IND) submissions.
	Reviews complex, cutting-edge preclinical programs in IND submissions to determine if there is adequate support for the rationale and safety of product administration in the proposed clinical trial.
	Evaluates the nonclinical sections of Biologics License Applications (BLAs).
	Represents the FDA at various scientific and regulatory meetings, as applicable.**BASIC QUALIFICATIONS:** This position is multidisciplinary, and applicants will be required to meet the specific qualification requirements of the applicable occupational series below. Occupational Series which may be considered include General Natural Resources Management and Biological Sciences (RG-0401), Pharmacology (RG-0405), Toxicology (RG-0415), Biomedical Engineering (RG-0858), and Veterinary Medical Science (RG-0701).

**ADDITIONAL QUALIFICATIONS:** Ph.D. or equivalent doctoral degree (M.D., D.V.M., or Sc.D., etc.) is required.

**PREFERRED SPECIALIZED EXPERIENCE:** Experience with research projects investigating gene therapy products, stem cell therapy, and/or regenerative medicine/tissue-engineered products, and experience conducting experiments in animals is highly desirable.

**FOREIGN EDUCATION:** If you are using education completed in foreign colleges or universities to meet the qualification requirements, you must show that the education credentials have been evaluated by a private organization that specializes in interpretation of foreign education programs and such education has been deemed equivalent to that gained in an accredited U.S. education program; or full credit has been given for the courses at a U.S. accredited college or university. *For further information, visit the U.S. Department of Education website for Foreign Education Evaluation.*

**ANNUAL SALARY:** $112, 015 - $145,617 (GS-13 equivalent). Salary is commensurate with education and experience, including an excellent benefits package.

**LOCATION:** FDA White Oak Campus in Silver Spring, MD.

**CONDITIONS OF EMPLOYMENT:** This position will be filled through the FDA’s Staff Fellowship Program, with an initial appointment period followed by opportunities for renewal. **Applications will be accepted from all groups of qualified candidates, including U.S. citizens or non-U.S. Citizens holding valid immigration status and work authorization at the FDA.** No previous Federal experience is required. Appointment does not confer any entitlement to a position in the competitive service, and during the initial appointment there is no entitlement to Merit Systems Protection Board (MSPB) appeals rights.

One-year probationary period may be required.
	Official Transcripts required.
	Background and/or Security investigation required.
	If applicant is an U.S. Citizen, males born on, or after, December 31st, 1959, must be registered with the Selective Service System or have an approved exemption. Visit the Selective Service System for more info.
	Prohibited financial interest restrictions may apply. For additional information on the prohibited financial interests, please visit the FDA Ethics and Integrity Office webpage.
	Non-US and permanent residents are required to have resided in the United States for a **minimum of three of the last five years**.**HOW TO APPLY:** Please submit your resume or curriculum vitae with a cover letter containing a brief summary of your scientific accomplishments to Iwen Wu at Iwen.Wu@fda.hhs.gov and Alyssa Galaro at Alyssa.Galaro@fda.hhs.gov. Applications and all supporting documentation will be accepted through **March 31, 2024**. Please reference Job Code: **OTP-24-01-CJP**.

HHS/FDA is an equal opportunity and affirmative action employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or protected veteran status.

DEPARTMENT OF HEALTH AND HUMAN SERVICES IS AN EQUAL OPPORTUNITY EMPLOYER WITH A SMOKE FREE ENVIRONMENT

                                                                                  Content current as of:
      01/09/2024
              
              
Regulated Product(s)
		 BiologicsCenter for Biologics Evaluation and Research (CBER)

          
                        CBER Offices & Divisions
          CBER Vision & Mission
          CBER Reports
          CBER Ombudsman
          CBER Product Jurisdiction
          Jobs at CBER
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop